ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ARDT - US03980N1072 - Common Stock
8.6 USD
-0.3 (-3.37%)
8.6 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to ARDT. ARDT was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ARDT get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on ARDT. These ratings could make ARDT a good candidate for value investing.
1. Profitability
1.1 Basic Checks
- ARDT had positive earnings in the past year.
- ARDT had a positive operating cash flow in the past year.
1.2 Ratios
- ARDT has a better Return On Assets (3.98%) than 70.00% of its industry peers.
- ARDT has a Return On Equity of 16.56%. This is amongst the best in the industry. ARDT outperforms 83.00% of its industry peers.
- ARDT has a Return On Invested Capital of 7.53%. This is in the better half of the industry: ARDT outperforms 70.00% of its industry peers.
- ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.19%.
- The 3 year average ROIC (5.96%) for ARDT is below the current ROIC(7.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.98% | ||
| ROE | 16.56% | ||
| ROIC | 7.53% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
- ARDT has a Profit Margin of 3.24%. This is in the better half of the industry: ARDT outperforms 69.00% of its industry peers.
- ARDT's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 5.98%, ARDT is in the better half of the industry, outperforming 67.00% of the companies in the same industry.
- ARDT's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 57.94%, ARDT belongs to the top of the industry, outperforming 81.00% of the companies in the same industry.
- ARDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.98% | ||
| PM (TTM) | 3.24% | ||
| GM | 57.94% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARDT is destroying value.
- ARDT has more shares outstanding than it did 1 year ago.
- Compared to 1 year ago, ARDT has an improved debt to assets ratio.
2.2 Solvency
- ARDT has an Altman-Z score of 2.02. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
- ARDT has a Altman-Z score of 2.02. This is comparable to the rest of the industry: ARDT outperforms 45.00% of its industry peers.
- The Debt to FCF ratio of ARDT is 7.03, which is on the high side as it means it would take ARDT, 7.03 years of fcf income to pay off all of its debts.
- ARDT has a Debt to FCF ratio (7.03) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.88 indicates that ARDT is somewhat dependend on debt financing.
- ARDT has a Debt to Equity ratio (0.88) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 7.03 | ||
| Altman-Z | 2.02 |
ROIC/WACC0.87
WACC8.62%
2.3 Liquidity
- A Current Ratio of 2.08 indicates that ARDT has no problem at all paying its short term obligations.
- ARDT has a better Current ratio (2.08) than 80.00% of its industry peers.
- ARDT has a Quick Ratio of 1.95. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.95, ARDT belongs to the top of the industry, outperforming 81.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 314.38% over the past year.
- ARDT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.75% yearly.
- The Revenue has grown by 10.29% in the past year. This is quite good.
- The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%
3.2 Future
- The Earnings Per Share is expected to grow by 7.97% on average over the next years.
- ARDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y-19.91%
EPS Next 2Y7.62%
EPS Next 3Y7.97%
EPS Next 5YN/A
Revenue Next Year8.69%
Revenue Next 2Y6.71%
Revenue Next 3Y6.36%
Revenue Next 5Y7.17%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 4.02, the valuation of ARDT can be described as very cheap.
- Based on the Price/Earnings ratio, ARDT is valued cheaper than 100.00% of the companies in the same industry.
- When comparing the Price/Earnings ratio of ARDT to the average of the S&P500 Index (27.47), we can say ARDT is valued rather cheaply.
- The Price/Forward Earnings ratio is 6.04, which indicates a rather cheap valuation of ARDT.
- Based on the Price/Forward Earnings ratio, ARDT is valued cheaply inside the industry as 99.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, ARDT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.02 | ||
| Fwd PE | 6.04 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaply inside the industry as 99.00% of the companies are valued more expensively.
- ARDT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ARDT is cheaper than 89.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.82 | ||
| EV/EBITDA | 3.34 |
4.3 Compensation for Growth
- ARDT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.62%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
- No dividends for ARDT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.6
-0.3 (-3.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-24 2026-02-24
Inst Owners74.95%
Inst Owner Change-0.01%
Ins Owners1.98%
Ins Owner Change-0.01%
Market Cap1.23B
Revenue(TTM)6.33B
Net Income(TTM)205.06M
Analysts77.89
Price Target14.01 (62.91%)
Short Float %2.5%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.03%
Min EPS beat(2)24.85%
Max EPS beat(2)71.2%
EPS beat(4)4
Avg EPS beat(4)53.83%
Min EPS beat(4)24.85%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.13%
Min Revenue beat(2)-0.08%
Max Revenue beat(2)4.33%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.87%
PT rev (3m)-28.89%
EPS NQ rev (1m)-11.41%
EPS NQ rev (3m)-50.73%
EPS NY rev (1m)-11.11%
EPS NY rev (3m)-47.58%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)-1.54%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.02 | ||
| Fwd PE | 6.04 | ||
| P/S | 0.19 | ||
| P/FCF | 7.82 | ||
| P/OCF | 3.36 | ||
| P/B | 0.99 | ||
| P/tB | 4.55 | ||
| EV/EBITDA | 3.34 |
EPS(TTM)2.14
EY24.88%
EPS(NY)1.42
Fwd EY16.56%
FCF(TTM)1.1
FCFY12.79%
OCF(TTM)2.56
OCFY29.77%
SpS44.18
BVpS8.65
TBVpS1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.98% | ||
| ROE | 16.56% | ||
| ROCE | 8.99% | ||
| ROIC | 7.53% | ||
| ROICexc | 8.81% | ||
| ROICexgc | 12.04% | ||
| OM | 5.98% | ||
| PM (TTM) | 3.24% | ||
| GM | 57.94% | ||
| FCFM | 2.49% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 7.03 | ||
| Debt/EBITDA | 2.05 | ||
| Cap/Depr | 137.15% | ||
| Cap/Sales | 3.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.06% | ||
| Profit Quality | 76.79% | ||
| Current Ratio | 2.08 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 2.02 |
F-Score8
WACC8.62%
ROIC/WACC0.87
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
EPS Next Y-19.91%
EPS Next 2Y7.62%
EPS Next 3Y7.97%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%
Revenue Next Year8.69%
Revenue Next 2Y6.71%
Revenue Next 3Y6.36%
Revenue Next 5Y7.17%
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year53.32%
EBIT Next 3Y17.64%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A
ARDENT HEALTH INC / ARDT FAQ
Can you provide the ChartMill fundamental rating for ARDENT HEALTH INC?
ChartMill assigns a fundamental rating of 5 / 10 to ARDT.
Can you provide the valuation status for ARDENT HEALTH INC?
ChartMill assigns a valuation rating of 8 / 10 to ARDENT HEALTH INC (ARDT). This can be considered as Undervalued.
Can you provide the profitability details for ARDENT HEALTH INC?
ARDENT HEALTH INC (ARDT) has a profitability rating of 6 / 10.
Can you provide the financial health for ARDT stock?
The financial health rating of ARDENT HEALTH INC (ARDT) is 5 / 10.